Nosocomial Bloodstream Infection in Critically Ill Adults

Pittet, Didier; Tarara, Debra T; Wenzel, Richard P.

doi:10.1097/00132586-199412000-00063

Cited by 39 publications

(56 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…88 This paper reports a pairwise-matched case-control study designed to determine the excess length of stay, extra costs and mortality attributable to nosocomial BSI in critically ill patients. The extra hospital and intensive care lengths of stay attributable to BSI were 24 and 8 days, respectively.…”

Section: Extra Cost Of a Crbsimentioning

confidence: 99%

“…The extra hospital and intensive care lengths of stay attributable to BSI were 24 and 8 days, respectively. Pittet 88 estimated that the average additional cost of a BSI was $40,000 per survivor. This figure is not specifically associated with CRBSIs; however, it is likely that the cost difference between a BSI and a CRBSI is minimal.…”

Section: Extra Cost Of a Crbsimentioning

confidence: 99%

See 1 more Smart Citation

The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation

Hockenhull¹,

Dwan²,

Boland³

et al. 2008

Health Technol Assess

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) Programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as royal colleges and NHS trusts. These sugges...

show abstract

Section: Extra Cost Of a Crbsimentioning

confidence: 99%

Section: Extra Cost Of a Crbsimentioning

confidence: 99%

The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation

Hockenhull¹,

Dwan²,

Boland³

et al. 2008

Health Technol Assess

View full text Add to dashboard Cite

show abstract

“…It has been recently found that the profile found in Brazil is similar to that of isolated strains in Portugal and Spain. This fact reinforces the possibility of differential virulence among the several MRSA strains, and perhaps, that the clone, peculiar to Brazil, Spain and Portugal is more virulent [29,[35][36][37] Predictive model of mortality. The estimates of death probabilities calculated for each subgroup of patients.…”

Section: Discussionmentioning

confidence: 55%

“…Nosocomial pneumonia is associated with an increased death risk, ranging from 20% to 84% [27- Septic shock is considered to be an important death risk factor among patients with bacteremia [24,29]. The mortality observed by Lundberg et al [31] among patients who developed septic shock ranged from 39% to 70%.…”

Section: Discussionmentioning

confidence: 99%

Staphylococcus aureus bacteremia: comparison of two periods and a predictive model of mortality

Conterno¹,

Wey²,

Castelo³

2002

Braz J Infect Dis

View full text Add to dashboard Cite

Staphylococcus aureus is an important pathogen causing bacteremia, primarily affecting hospitalized patients. We studied the epidemiology of S. aureus bacteremia, comparing two periods (early and mid 1990s) and developed a predictive model of mortality. A nested case-control was done. All 251 patients over 14 years old with positive blood cultures for S. aureus were selected. MRSA (methicillin resistant S. aureus) was isolated in 63% of the cases. When comparing the two periods MRSA community-acquired bacteremia increased from 4% to 16% (p=0.01). There was no significant difference in the mortality rate between the two periods (39% and 33%, p=0.40). Intravascular catheters provoked 24% of the cases of bacteremia and were associated with the lowest rate of mortality. In a logistic regression analysis, three variables were associated with death: septic shock, source of bacteraemia and resistance to methicillin. The probability of dying among patients with MRSA and those with methicillin sensitive S. aureus bacteraemia ranged from 10% to 90% and from 4% to 76%, respectively, depending on the source of the bacteraemia and the occurrence of septic shock. The MRSA found in Brazil may be a particularly virulent strain.

show abstract

“…Desafortunadamente, más del 15% de los pacientes con un CVC presenta alguna complicación relacionada (1)(2)(3)(4)(5)(6) (mecánica en 5-19% de los casos (3)(4)(5)7) ; infecciosa en el 5-26% (3,4,6,8) y trombótica en el 2-26% (3)(4) ), lo cual propicia un incremento de la morbimortalidad (3,(9)(10)(11)(12)(13) . Dentro de las complicaciones infecciosas está la septicemia, la cual pueden ser primaria (y que representa el 64% de las septicemias nosocomiales) o secundaria (relacionada con procesos infecciosos en otras regiones anatómicas, como por ejemplo tracto urinario, vías respiratorias inferiores, heridas quirúrgicas o piel) (14) .…”

Section: Discussionunclassified

Septicemia asociada a catéter venoso central

Cardoce

2012

RC_UCR-HSJD

View full text Add to dashboard Cite

Nosocomial Bloodstream Infection in Critically Ill Adults

Cited by 39 publications

References 0 publications

The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation

The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation

Staphylococcus aureus bacteremia: comparison of two periods and a predictive model of mortality

Septicemia asociada a catéter venoso central

Contact Info

Product

Resources

About